Stockscreener 앱 받기
1.2994
7.66%
-0.0706
시간 외 거래:
1.30
0.0006
+0.05%
전일 마감가:
$1.37
열려 있는:
$1.32
하루 거래량:
100.70K
Relative Volume:
0.08
시가총액:
$12.97M
수익:
$71.39M
순이익/손실:
$-28.60M
주가수익비율:
-1.6082
EPS:
-0.808
순현금흐름:
$-12.92M
1주 성능:
-22.39%
1개월 성능:
-26.02%
6개월 성능:
-19.94%
1년 성능:
-33.86%
1일 변동 폭
$1.24
$1.44
1주일 범위
$1.24
$1.68
52주 변동 폭
$1.0509
$3.55
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
TRIB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| TRIB | 1.2994 | 12.97M | 71.39M | -28.60M | -12.92M | -0.808 |
| ABT | 117.38 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.57 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.46 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.66 | 112.92B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.88B | 6.60B | 4.16B | 490.10M | 2.34 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2015-10-23 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2015-09-03 | 개시 | Raymond James | Outperform |
| 2015-07-29 | 재확인 | ROTH Capital | Buy |
| 2008-07-22 | 재확인 | Roth Capital | Buy |
| 2008-03-17 | 재확인 | Roth Capital | Buy |
| 2007-12-10 | 재확인 | Roth Capital | Buy |
| 2007-10-26 | 재확인 | Roth Capital | Buy |
모두보기
Trinity Biotech Plc Adr 주식(TRIB)의 최신 뉴스
Trinity Biotech Announces Q3 2024 Financial Results - GlobeNewswire Inc.
Trinity Biotech regains Nasdaq compliance - Investing.com India
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN
TRIBTrinity Biotech plc Latest Stock News & Market Updates - StockTitan
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech invests in rapid sepsis diagnostics firm By Investing.com - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com
Trinity Biotech acquires Metabolomics Diagnostics - Investing.com
TRIB underperforms with a -14.67 decrease in share price - US Post News
Balance Sheet Breakdown: Trinity Biotech Plc ADR (TRIB)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Trinity Biotech to launch CGM tech in India, seeks feedback - Investing.com India
Middle East & Africa Blood Testing Market Size & Outlook, 2030 - Grand View Research
India Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Germany Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Indonesia Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Trinity Biotech names new Chief Commercial Officer - Investing.com
It is Poised to be a Bull Market for Trinity Biotech Plc ADR (TRIB) - SETE News
Market Recap: Trinity Biotech Plc ADR (TRIB)’s financial ratios: A comprehensive overview - The Dwinnex
Examining Trinity Biotech Plc ADR (TRIB) stock is warranted - US Post News
Trinity Biotech Plc ADR (TRIB) is looking forward to a strong quarter - SETE News
A Tale of Resilience: Trinity Biotech Plc ADR Amid Stock Market Turbulence - The InvestChronicle
Ratios Reveal: Breaking Down Trinity Biotech Plc ADR (TRIB)’s Financial Health - The Dwinnex
Martin Shkreli ordered to give up all copies of one-of-a-kind Wu-Tang Clan album - CNN
Trinity Biotech raises 2024 sales forecast for HIV test - Investing.com India
Li Auto Inc. Sponsored ADR (LI) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Trinity Biotech appoints new biosensor marketing director - Investing.com India
Why PDD Holdings Inc. Sponsored ADR (PDD) Outpaced the Stock Market Today - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Laps the Stock Market: Here's Why - Yahoo Finance
Contrast Security Application Detection and Response (ADR) Praised by Industry Analysts for Addressing Gap in Cybersecurity Defenses - Yahoo Finance
Trinity Biotech gets extension to meet Nasdaq listing rules - Investing.com India
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Trinity Biotech projects Q2 revenue growth, UK deal - Investing.com
Biotech Stock Roundup: BMY, GSK, BIIB's Q2 Results, VTVT Down on Setback - Yahoo Finance
Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y - Yahoo Finance
Sea Limited Sponsored ADR (SE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Legend Biotech (LEGN) Up 12% on Reports of Takeover Bid - Yahoo Finance
Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last? - Yahoo Finance
Is Bayerische Motoren Werke AG Sponsored ADR (BMWYY) Stock Undervalued Right Now? - Yahoo Finance
Trinity Biotech appoints new CFO - Investing.com India
Trinity Biotech appoints new CFO By Investing.com - Investing.com
Kintara Therapeutics restructures share designations By Investing.com - Investing.com
Trinity Bio ADR (TRIB-Q) QuotePress Release - The Globe and Mail
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading - MSN
XPeng Inc. Sponsored ADR (XPEV) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates - Yahoo Finance
Trinity Biotech Plc Adr (TRIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
0.24%
자본화:
|
볼륨(24시간):